Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.610
-0.070 (-1.90%)
Mar 6, 2026, 11:08 AM EST - Market open
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nucleic Acid Production | 119.79M | 127.09M | 155.58M | 182.98M | 200.24M | 217.17M | 214.55M | 209.33M | |||||||||||||
| Nucleic Acid Production Growth | -40.18% | -41.48% | -27.49% | -12.59% | -10.91% | -38.87% | -55.20% | -67.84% | |||||||||||||
| Biologics Safety Testing | 65.96M | 65.35M | 64.25M | 62.86M | 62.92M | 63.58M | 64.03M | 64.77M | |||||||||||||
| Biologics Safety Testing Growth | 4.83% | 2.79% | 0.34% | -2.95% | -1.96% | -1.10% | -1.53% | -3.13% | |||||||||||||
| Protein Detection | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.44M | 26.24M | 23.31M | 22.88M |
Adjusted EBITDA by Segment
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biologics Safety Testing | 44.24M | 43.61M | 44.00M | 42.59M | 43.84M | 45.90M | 46.22M | 47.09M | |||||||||||||
| Biologics Safety Testing Growth | 0.91% | -4.98% | -4.80% | -9.56% | -6.54% | -1.33% | -4.25% | -9.54% | |||||||||||||
| Nucleic Acid Production | -23.15M | -20.12M | 3.25M | 31.83M | 50.81M | 70.85M | 71.98M | 64.87M | |||||||||||||
| Nucleic Acid Production Growth | - | - | -95.48% | -50.94% | -38.53% | -63.50% | -76.88% | -86.58% |
Revenue by Geography
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 112.38M | 111.65M | 121.31M | 122.99M | 127.09M | 132.08M | 131.91M | 133.92M | |||||||||||||
| North America Growth | -11.58% | -15.47% | -8.03% | -8.16% | -9.90% | -24.52% | -44.62% | -54.30% | |||||||||||||
| EMEA | 41.47M | 30.92M | 30.42M | 39.57M | 42.06M | 50.53M | 50.69M | 50.30M | |||||||||||||
| EMEA Growth | -1.38% | -38.81% | -40.00% | -21.33% | -15.76% | -61.36% | -75.27% | -83.56% | |||||||||||||
| APAC | 30.92M | 48.96M | 63.54M | 78.80M | 89.38M | 93.60M | 95.30M | 89.21M | |||||||||||||
| APAC Growth | -65.40% | -47.69% | -33.33% | -11.67% | -8.27% | -17.24% | -4.65% | -24.38% | |||||||||||||
| Latin and Central America | 971.00K | 757.00K | 586.00K | 501.00K | 662.00K | 706.00K | 686.00K | 681.00K | |||||||||||||
| Latin and Central America Growth | 46.68% | 7.22% | -14.58% | -26.43% | 25.62% | 8.78% | -14.04% | -19.60% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.